Kolexia
Weiss Laurence
Médecine générale
Hôpital Européen Georges Pompidou
Paris, France
113 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Infections à papillomavirus Tumeurs de l'anus Hépatite Hépatite C COVID-19 Hépatite C chronique Syndrome d'immunodéficience acquise Carcinome épidermoïde

Industries

MSD
23 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
2 collaboration(s)
Dernière en 2020
OVERCOME
1 collaboration(s)
Dernière en 2020
Gilead
1 collaboration(s)
Dernière en 2021

Dernières activités

HCV RNA Quantification by a Domestic Commercial Assay: A Case Study among People Who Inject Drugs in Vietnam.
Diagnostics (Basel, Switzerland)   16 novembre 2023
DRIVE-C: Towards HCV Elimination: Evaluation of an Integrated Model of HCV Care Targeting People Who Inject Drugs in Hai Phong, Vietnam
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   25 octobre 2023
A community-based strategy to eliminate hepatitis C among people who inject drugs in Vietnam.
The Lancet regional health. Western Pacific   27 mai 2023
Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs).
Oncoimmunology   11 mai 2023
Decrease in CD4 T-Cell Count and Risk of Severe Morbid Conditions in People With Human Immunodeficiency Virus Infection With Controlled Viral Load After Initiating Combination Antiretroviral Therapy Between 2006 and 2018.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   19 avril 2023
Mortality in hepatitis C virus-cured vs. hepatitis C virus-uninfected people with HIV.
AIDS (London, England)   05 avril 2023
Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control.
The Journal of clinical investigation   17 janvier 2023
Résultats intermédiaires sur les 658 premiers patients de l’étude PRAISE (Patient-Reported AutoImmunity SEcondary to cancer immunotherapy) : étude de cohorte prospective multicentrique pour le suivi des manifestations auto-immunes sous immunothérapie
35e Congrès Français de Rhumatologie   01 décembre 2022
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   01 août 2022
Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control.
The Journal of clinical investigation   02 juin 2022